Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1985-12-23
1987-03-10
Michl, Paul R.
Drug, bio-affecting and body treating compositions
Lymphokine
A61K 704
Patent
active
046490485
ABSTRACT:
Particular quaternized vinylimidazole-ethylene glycol dimethacrylate copolymers are useful to sequester non-absorbed bile acids in the intestinal tract to form a complex which is excreted in the feces.
REFERENCES:
patent: 2603621 (1952-07-01), Craig et al.
patent: 2840550 (1958-06-01), Price et al.
patent: 2891025 (1959-06-01), Price
patent: 3234150 (1966-02-01), Feldt et al.
patent: 3308020 (1967-03-01), Wolf et al.
patent: 3329560 (1967-07-01), von Schickh et al.
patent: 3803302 (1974-04-01), Miner et al.
patent: 4163092 (1979-07-01), Steckler
patent: 4349651 (1982-09-01), Smith
patent: 4471097 (1984-09-01), Uhl et al.
AMA Drug Evaluations, 5th Ed., Am. Med. Assoc., Chicago, Ill., 1983, pp. 1237, 1289; 1290 Ibid, pp. 1240 and 1662.
Bristol-Myers Company
Johnson Lester E.
Michl Paul R.
LandOfFree
Novel bile sequestrant resin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel bile sequestrant resin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel bile sequestrant resin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1021190